Dizal Pharmaceutical Co., Ltd.

Time frame: 1 April 2023 - 31 March 2024

Region or country/territory

Sector

Subject or journal group

Article ‘Count’ and ‘Share’ for Dizal Pharmaceutical Co., Ltd. based on listed parameters only.

The articles listed below published by authors from Dizal Pharmaceutical Co., Ltd., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.

Journal	Count	Share
The Lancet Oncology	1	0.03

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Latest supplement

Nature Index 2024 China

China's status at the summit of the Nature Index remains unrivalled as the gap between it and the United States grows. The key question is where Chinese research will go next. As the nation seeks international recognition for its scientific achievements, betting big on large-scale experiments, it is also carving its own path in publishing and partnerships. Time will tell how these strategies will shift the status quo of the global research landscape.

Access free

Nature Strategy Reports

Comprehensive deep-dives and custom high-quality reports into relevant research topics to influence major research and funding decisions.

Learn more

Explore the topics behind the 75,000 papers in the Nature Index 2024 Research Leaders

FREE ACCESS Explore